New opportunities in the diagnosis and treatment of overactive bladder and urgent urinary incontinence according to the updated clinical guidelines on urinary incontinence (2024)

Gadzhieva Z.K.

National Medical Research Center for «Urology», FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia

The main changes and additions to the clinical guidelines "Urinary Incontinence" (2024) are presented in the review. Certain changes to the guidelines "Urinary Incontinence" developed by the Russian Society of Urologists (RSU) and approved by the Ministry of Health of the Russia became possible thanks to the work of the expert Councils, which include the national leading specialists dealing with the problem of urination disorders. The inclusion of the Russian drug in the clinical guidelines will allow regulating the prescription of bladder polypeptides (Vesusten) in the routine clinical practice of a urologist and will help a wider range of patients receive pathogenetic therapy for OAB/urgent urinary incontinence.

Keywords

About the Authors

Corresponding author: Z.K. Gadzhieva – Ph.D., MD, Head of the Department of analysis of personnel policy, educational programs and scientific research of the National Medical Research Center for «Urology», FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia, scientific editor of the journal “Urologiia”; e-mail: gadzhieva_z_k@staff.sechenov.ru

Similar Articles